Nexodal (Naloxone Hydrochloride)

Naloxone hydrochloride, the active ingredient in Nexodal, is an opioid antagonist presented as an injectable solution for intramuscular and intravenous use. It rapidly reverses the effects of opioid overdose in emergency situations for patients of all ages. GNH USA supplies Nexodal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexodal is an opioid antagonist used in the management of opioid‑related emergencies. - Opioid overdose: restores normal breathing and consciousness by reversing respiratory depression. - Opioid‑induced sedation: rapidly awakens patients with excessive sedation. - Acute opioid toxicity: counteracts life‑threatening effects of opioid agonists in emergency care.

Adverse reactions may occur following administration of naloxone.

Common Side Effects: - Injection site pain or irritation - Nausea or vomiting - Sweating or flushing - Headache - Dizziness or light‑headedness

Serious or Rare Side Effects: - Acute withdrawal syndrome (agitation, hypertension, tachycardia) - Cardiac arrhythmias - Seizures (rare) - Severe hypotension

When using Nexodal, consider the following safety measures. - Cardiovascular monitoring: watch for hypertension, tachycardia, or arrhythmias during reversal. - Withdrawal risk: patients dependent on opioids may experience acute withdrawal; be prepared to manage symptoms. - Respiratory support: ensure airway and breathing are maintained after administration. - Concomitant drugs: assess for other central nervous system depressants that may affect response. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxone may interact with other substances that affect the central nervous system.

Major Interactions (Avoid): - Concurrent use of high‑dose opioid agonists: may require repeated naloxone dosing and can precipitate severe withdrawal. - Benzodiazepines or barbiturates: combined CNS depression may blunt naloxone’s effect on respiratory drive.

Moderate Interactions (Monitor Closely): - Sympathomimetic agents (e.g., epinephrine): may exacerbate hypertension during withdrawal. - Antihypertensive medications: monitor blood pressure as naloxone‑induced catecholamine surge can counteract their effect. - MAO inhibitors: observe for atypical reactions during opioid reversal.